Thomas Dorlo

Dikutip oleh

	Semua	Sejak 2020
Kutipan	4382	2396
indeks-h	33	26
indeks-i10	72	60

560

280

140

420

201020112012201320142015201620172018201920202021202220232024202518 23 66 135 171 203 274 324 345 340 338 461 440 495 560 99

Akses publik

Lihat semua

52 artikel

0 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

Professor Ahmed Mudawi MusaInstitute of Endemic Diseases, University of Khartoum,Email yang diverifikasi di uofk.edu
Boelaert MProfessor of Epidemiology and Control of Neglected Tropical Diseases, Institute of Tropical MedicineEmail yang diverifikasi di itg.be
Jean-Claude DujardinInstitute of Tropical MedicineEmail yang diverifikasi di itg.be
Eltahir Awad Gasim KhalilProfessor of Haematology/immunohaematology, University of Khartoum, SudanEmail yang diverifikasi di iend.org
Brima Musa YounisLecturer, University of KhartoumEmail yang diverifikasi di uofk.edu
Asrat HailuProfessor Immunoparasitology, Addis Ababa UniversityEmail yang diverifikasi di aau.edu.et
Surendra UranwB.P. Koirala Institute of Health Sciences, Dharan, NepalEmail yang diverifikasi di bpkihs.edu
Raymond OmolloDrugs for Neglected Diseases Initiative AfricaEmail yang diverifikasi di dndi.org
George KirigiPAC universityEmail yang diverifikasi di students.pacuniversity.ac.ke
Tansy EdwardsLondon School of Hygiene & Tropical MedicineEmail yang diverifikasi di lshtm.ac.uk
Narayan Raj BhattaraiB P Koirala Institute of Health Sciences, DharanEmail yang diverifikasi di bpkihs.edu
Jaap Jan BoelensChief, Transplantation and Cellular Therapies” @ Memorial Sloan Kettering Cancer CenterEmail yang diverifikasi di mskcc.org
Julie JanssenEmail yang diverifikasi di pharmetheus.com
Shyam SundarDistinguished Professor of Medicine, Banaras Hindu UniversityEmail yang diverifikasi di bhu.ac.in
David DamoiseauxAssociate Consultant, PharmetheusEmail yang diverifikasi di pharmetheus.com
Rupa SinghProfessor, Pediatrics, TMMC & RC, TMUEmail yang diverifikasi di tmu.ac.in
Maria Adelaida GomezCoordinator of the Molecular Biology and Biochemistry Unit, CIDEIMEmail yang diverifikasi di cideim.org.co
Manu VanaerschotRoche Diagnostics, Infectious DiseasesEmail yang diverifikasi di roche.com
Neeltje SteeghsMD, PhD, Netherlands Cancer InstituteEmail yang diverifikasi di nki.nl
Neal Alexander1) London School of Hygiene & Tropical Medicine, 2) CIDEIMEmail yang diverifikasi di lshtm.ac.uk

Ikuti

Thomas Dorlo

Professor of Pharmacometrics, Uppsala University

Email yang diverifikasi di uu.se - Beranda

Clinical Pharmacology Pharmacometrics Tropical Medicine Neglected Tropical Diseases


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis TPC Dorlo, M Balasegaram, JH Beijnen, PJ de Vries Journal of Antimicrobial Chemotherapy 67 (11), 2576-2597, 2012	889	2012
Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance S Rijal, B Ostyn, S Uranw, K Rai, NR Bhattarai, TPC Dorlo, JH Beijnen, ... Clinical Infectious Diseases 56 (11), 1530-1538, 2013	373	2013
Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients TPC Dorlo, PPAM van Thiel, ADR Huitema, RJ Keizer, HJC de Vries, ... Antimicrobial agents and chemotherapy 52 (8), 2855-2860, 2008	208	2008
Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure TPC Dorlo, S Rijal, B Ostyn, PJ de Vries, R Singh, N Bhattarai, S Uranw, ... The Journal of infectious diseases 210 (1), 146-153, 2014	160	2014
LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014 J Blum, P Buffet, L Visser, G Harms, MS Bailey, E Caumes, J Clerinx, ... Journal of travel medicine 21 (2), 116-129, 2014	142	2014
Optimal dosing of miltefosine in children and adults with visceral leishmaniasis TPC Dorlo, ADR Huitema, JH Beijnen, PJ de Vries Antimicrobial agents and chemotherapy 56 (7), 3864-3872, 2012	132	2012
Efficacy and safety of AmBisome in combination with sodium stibogluconate or miltefosine and miltefosine monotherapy for African visceral leishmaniasis: phase II randomized trial M Wasunna, S Njenga, M Balasegaram, N Alexander, R Omollo, ... PLoS neglected tropical diseases 10 (9), e0004880, 2016	91	2016
Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia B Ostyn, E Hasker, TPC Dorlo, S Rijal, S Sundar, JC Dujardin, M Boelaert PloS one 9 (6), e100220, 2014	90	2014
Safety and efficacy of single dose versus multiple doses of AmBisome® for treatment of visceral leishmaniasis in eastern Africa: a randomised trial EAG Khalil, T Weldegebreal, BM Younis, R Omollo, AM Musa, W Hailu, ... PLoS neglected tropical diseases 8 (1), e2613, 2014	89	2014
Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samples AE Kip, KC Kiers, H Rosing, JHM Schellens, JH Beijnen, TPC Dorlo Journal of pharmaceutical and biomedical analysis 135, 160-166, 2017	86	2017
Clinical pharmacokinetics of systemically administered antileishmanial drugs AE Kip, JHM Schellens, JH Beijnen, TPC Dorlo Clinical pharmacokinetics 57 (2), 151-176, 2018	82	2018
Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East … R Omollo, N Alexander, T Edwards, EAG Khalil, BM Younis, AA Abuzaid, ... Trials 12, 1-10, 2011	74	2011
Systematic review of biomarkers to monitor therapeutic response in leishmaniasis AE Kip, M Balasegaram, JH Beijnen, JHM Schellens, PJ de Vries, ... Antimicrobial agents and chemotherapy 59 (1), 1-14, 2015	73	2015
Population pharmacokinetics of fludarabine in children and adults during conditioning prior to allogeneic hematopoietic cell transplantation JB Langenhorst, TPC Dorlo, EM van Maarseveen, S Nierkens, J Kuball, ... Clinical pharmacokinetics 58, 627-637, 2019	71	2019
Development and validation of a quantitative assay for the measurement of miltefosine in human plasma by liquid chromatography–tandem mass spectrometry TPC Dorlo, MJX Hillebrand, H Rosing, TA Eggelte, PJ de Vries, ... Journal of Chromatography B 865 (1-2), 55-62, 2008	68	2008
Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes JB Langenhorst, C Van Kesteren, EM Van Maarseveen, TPC Dorlo, ... Blood advances 3 (14), 2179-2187, 2019	66	2019
Pharmacokinetics of miltefosine in children and adults with cutaneous leishmaniasis MM Castro, MA Gomez, AE Kip, A Cossio, E Ortiz, A Navas, TPC Dorlo, ... Antimicrobial agents and chemotherapy 61 (3), 10.1128/aac. 02198-16, 2017	66	2017
Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults P Byakika-Kibwika, M Lamorde, V Okaba-Kayom, H Mayanja-Kizza, ... Journal of antimicrobial chemotherapy 67 (5), 1217-1223, 2012	61	2012
Characterization and identification of suspected counterfeit miltefosine capsules TPC Dorlo, TA Eggelte, PJ de Vries, JH Beijnen Analyst 137 (5), 1265-1274, 2012	59	2012
Severe encephalopathy and polyneuropathy induced by dichloroacetate D Brandsma, TPC Dorlo, JH Haanen, JH Beijnen, W Boogerd Journal of neurology 257, 2099-2100, 2010	57	2010

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama